Found 10 matching trials
Intratumoral Administration of Daromun in Non-melanoma Skin Cancer Patients
PHASE2This clinical phase II study is designed to investigate the efficacy of int...
Location
Universitätsklinikum Augsburg
Intratumoral Administration of L19IL2/L19TNF
PHASE2This Phase II study is an uncontrolled, multicenter, prospective study for ...
Location
Fondazione IRCCS Istituto Nazionale dei Tumori
Efficay and Safety of DAROMUN on Patient Treated by Intralesionnal Injection: DAROMEL
N/AMelanoma is a malignant tumor originating from melanocytes, with a high met...
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
PHASE3The trial aims to evaluate the efficacy of Daromun neoadjuvant treatment fo...
Location
Mayo Clinic Hospital
L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma
PHASE2Open-label, single-arm, multicenter study in patients with locally advanced...
Location
UC Irvine Health- Chao Family Comprehensive Cancer Center
L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)
PHASE2Open label, randomized study in patients with LaBCC not eligible or refusin...
Location
H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc.
Neoadjuvant L19IL2/L19TNF- Pivotal Study
PHASE3Phase III, open-label, randomized, controlled multi-center study of the eff...
Status
Active Not Recruiting
Location
Hôpital de la Timone
L19IL2/L19TNF in Skin Cancer Patients
PHASE2Phase II, open label, multicentric, proof-of-principle basket trial in pati...
Location
Hôpital de la Timone
Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination with Pembrolizumab, in Unresectable Melanoma Patients
PHASE2The trial aims to evaluate the efficacy of single agent L19IL2, single agen...
Location
Memorial Sloan Kettering Cancer Center
L19IL2/TNF in Patients With Basal Cell Carcinoma
PHASE2Open-label, single-arm, multicentre study in patients with locally advanced...
Location
H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc.